These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 35501296)

  • 21. Association Between Proton Pump Inhibitor Use and Risk of Fracture in Children.
    Wang YH; Wintzell V; Ludvigsson JF; Svanström H; Pasternak B
    JAMA Pediatr; 2020 Jun; 174(6):543-551. PubMed ID: 32176276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparing proton pump inhibitors with histamin-2 receptor blockers regarding the risk of osteoporotic fractures: a nested case-control study of more than 350,000 Korean patients with GERD and peptic ulcer disease.
    Park JH; Lee J; Yu SY; Jung JH; Han K; Kim DH; Rhee J
    BMC Geriatr; 2020 Oct; 20(1):407. PubMed ID: 33059626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proton-pump inhibitors and risk of fractures: an update meta-analysis.
    Zhou B; Huang Y; Li H; Sun W; Liu J
    Osteoporos Int; 2016 Jan; 27(1):339-47. PubMed ID: 26462494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between proton pump inhibitor use and longitudinal change in bone mineral density: a population-based study [corrected] from the Canadian Multicentre Osteoporosis Study (CaMos).
    Targownik LE; Leslie WD; Davison KS; Goltzman D; Jamal SA; Kreiger N; Josse RG; Kaiser SM; Kovacs CS; Prior JC; Zhou W;
    Am J Gastroenterol; 2012 Sep; 107(9):1361-9. PubMed ID: 22777336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term proton pump inhibitor therapy and risk of hip fracture.
    Yang YX; Lewis JD; Epstein S; Metz DC
    JAMA; 2006 Dec; 296(24):2947-53. PubMed ID: 17190895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of proton pump inhibitors on fracture risk: report from the Canadian Multicenter Osteoporosis Study.
    Fraser LA; Leslie WD; Targownik LE; Papaioannou A; Adachi JD;
    Osteoporos Int; 2013 Apr; 24(4):1161-8. PubMed ID: 22890365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proton Pump Inhibitors and Fracture Risk: A Review of Current Evidence and Mechanisms Involved.
    Thong BKS; Ima-Nirwana S; Chin KY
    Int J Environ Res Public Health; 2019 May; 16(9):. PubMed ID: 31060319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of proton pump inhibitors and risk of osteoporosis-related fractures.
    Targownik LE; Lix LM; Metge CJ; Prior HJ; Leung S; Leslie WD
    CMAJ; 2008 Aug; 179(4):319-26. PubMed ID: 18695179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study.
    Pouwels S; Lalmohamed A; Souverein P; Cooper C; Veldt BJ; Leufkens HG; de Boer A; van Staa T; de Vries F
    Osteoporos Int; 2011 Mar; 22(3):903-10. PubMed ID: 20585937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship between proton pump inhibitor adherence and fracture risk in the elderly.
    Ding J; Heller DA; Ahern FM; Brown TV
    Calcif Tissue Int; 2014 Jun; 94(6):597-607. PubMed ID: 24706060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proton-pump inhibitor use and hip fractures in men: a population-based case-control study.
    Adams AL; Black MH; Zhang JL; Shi JM; Jacobsen SJ
    Ann Epidemiol; 2014 Apr; 24(4):286-90. PubMed ID: 24507954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hip and Subtrochanteric or Femoral Shaft Fractures after Bisphosphonate Use in Korean Women, Using Korean National Sample Cohort.
    Won SH; Ahn S; Ji E; Park JW; Kim JK; Lee YK
    J Korean Med Sci; 2020 Jun; 35(25):e193. PubMed ID: 32597040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proton pump inhibitor use and the antifracture efficacy of alendronate.
    Abrahamsen B; Eiken P; Eastell R
    Arch Intern Med; 2011 Jun; 171(11):998-1004. PubMed ID: 21321287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study of the association between hip fracture and acid-suppressive drug use in a UK primary care setting.
    Cea Soriano L; Ruigómez A; Johansson S; García Rodríguez LA
    Pharmacotherapy; 2014 Jun; 34(6):570-81. PubMed ID: 24634193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proton pump inhibitors and chronic kidney disease risk: a comparative study with histamine-2 receptor antagonists.
    Kweon T; Kim Y; Lee KJ; Seo WW; Seo SI; Shin WG; Shin DH
    Sci Rep; 2023 Dec; 13(1):21169. PubMed ID: 38036592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative risk of Clostridium difficile infection between proton pump inhibitors and histamine-2 receptor antagonists: A 15-year hospital cohort study using a common data model.
    Seo SI; You SC; Park CH; Kim TJ; Ko YS; Kim Y; Yoo JJ; Kim J; Shin WG
    J Gastroenterol Hepatol; 2020 Aug; 35(8):1325-1330. PubMed ID: 31970824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proton pump inhibitor use and the risk for Parkinson's disease: A nationwide population-based study in Taiwan.
    Chen HL; Lei WY; Wang JH; Bair MJ; Chen CL
    Medicine (Baltimore); 2023 May; 102(19):e33711. PubMed ID: 37171333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proton pump inhibitor use and risk of hip fractures in patients without major risk factors.
    Kaye JA; Jick H
    Pharmacotherapy; 2008 Aug; 28(8):951-9. PubMed ID: 18657011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peptic Ulcer Disease and Risk of Hip Fracture: A General Population-based Cohort Study.
    Li J; Lu N; Lyu H; Lei G; Zeng C; Wei J; Wang Y; Xie D
    J Clin Endocrinol Metab; 2022 Aug; 107(9):e3738-e3746. PubMed ID: 35689555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study.
    Abtahi S; Driessen JHM; Burden AM; Souverein PC; van den Bergh JP; van Staa TP; Boonen A; de Vries F
    Ann Rheum Dis; 2021 Apr; 80(4):423-431. PubMed ID: 33310727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.